Biozenta is well-experienced in Technology Transfer for products and formulations having experienced team with wide knowledge for Transfer of Technology (TechXfer) to the manufacturing company worldwide in any country. The Transfer of Technology includes layout preparation of manufacturing facilities with all utilities of all categories and the process development and analytical development for various product categories - Oncology, Anti-cancer, Cytotoxic, Critical-care, Life-saving, General Injectables, Contrast Media Injectables, Oral Solids - Tablets and Capsules, along with the proper guidance for the execution of plant till stability validation.
Biozenta is experienced with the manufacturing of various types of dosage forms of products which have higher coverage in MOH Tender items for hospital uses. The bulky items need high transportation costs, so local purchasing is economical and preferable by MOH. Similarly, in these times of globalization, the economical bulk drugs are the available world over, so one country is not competent to give a complete range of bulk drugs at affordable pricing.
Biozenta can guide and support the transfer of technology for various dosage forms - Oncology, Anti-cancer, Cytotoxic, Critical-care, Life-saving, General Injectables, Contrast Media Injectables, Oral Solids - Tablets and Capsules, etc. Biozenta welcome prospective clients who are interested to set up a unit in their country for MOH supplies and domestic marketing in their country.
Biozenta proposes one of the best proposals for setting up a manufacturing plant / facility / partnership:
1. Research Phase:
2. Development Phase:
3. Production Phase:
Biozenta is ready to establish both types of organizations for a prospective customer. The complete unit for manufacturing can be installed according to the capacity required by the prospective customer. The agreement to transfer technology can be finalized by mutual agreement with mutual terms and conditions and business case in place.